Aurinia Pharmaceuticals Inc. — Institutional Ownership
Which tracked institutions hold AUPH, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
24
Funds holding
$281280282
Total value held
Buying
19 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $116270621 | 7845521 | -82608 | -1.04% |
| 2 | State Street Corp | $37451607 | 2527099 | +25107 | +1.00% |
| 3 | Morgan Stanley | $33086365 | 2232548 | +15633 | +0.71% |
| 4 | Goldman Sachs Group Inc | $21244588 | 1433508 | +427175 | +42.45% |
| 5 | Nomura Holdings Inc | $14359246 | 968910 | — | NEW BUY |
| 6 | Northern Trust Corp | $12213236 | 824105 | +23961 | +2.99% |
| 7 | Janus Henderson Group Plc | $11225433 | 757435 | — | NEW BUY |
| 8 | Prudential Financial Inc | $8752840 | 590610 | +218050 | +58.53% |
| 9 | Bank Of America Corp /De/ | $5509794 | 371781 | +4145 | +1.13% |
| 10 | Bank Of New York Mellon Corp | $4976189 | 335775 | +6422 | +1.95% |
| 11 | Wells Fargo & Company/Mn | $4214532 | 264234 | +190241 | +257.11% |
| 12 | Raymond James Financial Inc | $3938522 | 265757 | +33342 | +14.35% |
| 13 | Franklin Resources Inc | $1963754 | 132507 | -56 | -0.04% |
| 14 | Principal Financial Group Inc | $1825513 | 123179 | +7964 | +6.91% |
| 15 | Invesco Ltd. | $1394555 | 87433 | -17637 | -16.79% |
| 16 | Marex Group Plc | $741000 | 50000 | -250000 | -83.33% |
| 17 | Ameriprise Financial Inc | $658720 | 44448 | +33845 | +319.20% |
| 18 | Barclays Plc | $444600 | 30000 | — | NEW BUY |
| 19 | Sei Investments Co | $305965 | 20645 | — | NEW BUY |
| 20 | Toronto Dominion Bank | $226672 | 15295 | — | NEW BUY |
| 21 | Us Bancorp \De\ | $177899 | 12004 | +44 | +0.37% |
| 22 | Royal Bank Of Canada | $163000 | 10977 | — | NEW BUY |
| 23 | Citigroup Inc | $121730 | 7632 | -9938 | -56.56% |
| 24 | Pnc Financial Services Group, Inc. | $13901 | 938 | +237 | +33.81% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.